Zacks Investment Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Zacks Investment Management's EXAS Position: Q1 2026 in Review
Zacks Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,309 shares — an estimated $234K sold.
Zacks Investment Management first reported a position in EXAS in Q1 2017 and held it in 7 quarters. The position peaked at $5.56M in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Zacks Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Zacks Investment Management sold 2,309 Exact Sciences shares in Q1 2026, an estimated $234K.
- Zacks Investment Management first reported a position in Exact Sciences in Q1 2017 and held it in 7 quarters.
- Zacks Investment Management's Exact Sciences position peaked at $5.56M in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.